Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: A HuGE review

American Journal of Epidemiology

Volumn 156, Issue 2, 2002, Pages 95-109

  Engel, Lawrence S ^a   Taioli, Emanuela ^b   Pfeiffer, Ruth ^a   Garcia Closas, Montserrat ^a   Marcus, Pamela M ^a   Lan, Qing ^a   Boffetta, Paolo ^c   Vineis, Paolo ^d   Autrup, Herman ^e   Bell, Douglas A ^f   Branch, Robert A ^g   Brockmöller, Jürgen ^h   Daly, Ann K ⁱ   Heckbert, Susan R ^j   Kalina, Ivan ^k   Kang, Daehee ^l   Katoh, Takahiko ^m   Lafuente, Amalia ⁿ   Lin, Henry J ^o   Romkes, Marjorie ^g   Taylor, Jack A ^f   Rothman, Nathaniel ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d UNIVERSITY OF TURIN   (Italy)

^e AARHUS UNIVERSITY   (Denmark)

^f NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h UNIVERSITY OF GÖTTINGEN   (Germany)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

^j UNIVERSITY OF WASHINGTON   (United States)

^k P J AFÁRIK UNIVERSITY   (Slovakia)

^l Seoul National University   (South Korea)

^m UNIVERSITY OF MIYAZAKI   (Japan)

ⁿ UNIVERSITY OF BARCELONA   (Spain)

^o HARBOR UCLA MEDICAL CENTER   (United States)

more..

Author keywords

Bladder neoplasms; Epidemiology; Genetics; Glutathione transferase

Indexed keywords

GENE PRODUCT; GLUTATHIONE TRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE;

CANCER; META-ANALYSIS;

ASIAN; BLADDER CANCER; CAUCASIAN; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; GENE DELETION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; REVIEW; RISK FACTOR; SMOKING;

BENZO(A)PYRENE; CARCINOGENS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; EUROPE; GENOTYPE; GLUTATHIONE TRANSFERASE; GREAT BRITAIN; HUMANS; JAPAN; KOREA; ODDS RATIO; RISK FACTORS; SMOKING; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 0037100373     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwf018     Document Type: Review

References (150)

1. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance
2. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility
3. Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class mu gene detected by polymerase chain reaction
4. Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls
5. Glutathione transferase activity and isoenzyme composition in primary human breast cancers
6. Genotype and phenotype of glutathione S-transferase mu in testicular cancer patients
7. Glutathione S-transferase mu locus: Use of genotyping and phenotyping assays to assess association with lung cancer susceptibility
8. Glutathione S-transferase polymorphisms and colorectal cancer: A HuGE review
9. GSTM1, GSTT1, and risk of squamous cell carcinoma of the head and neck
10. Metabolic gene polymorphism frequencies in control populations
11. Bladder cancer
12. Estimates of the worldwide incidence of 25 major cancers in 1990
13. Epidemiology and etiology of premalignant and malignant urothelial changes
14. Histologic features of bladder cancer in Boston, USA, Manchester, UK, and Nagoya, Japan
15. Bladder cancer
16. Urothelial cancer in white and Japanese patients in Hawaii: Pathology
17. Carcinoma of the urinary bladder associated with schistosomiasis in Egypt: The possible causal relationship
18. Bladder cancer: Epidemiology and risk factors in Bulawayo, Zimbabwe
19. Bladder cancer in Africa: Update
20. Cancer incidence, mortality, and survival among racial and ethnic minority groups in the United States
21. Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studies
22. Levelling-off of the risk of lung and bladder cancer in heavy smokers: An analysis based on multicentric case-control studies and a metabolic interpretation
23. Changing cigarette habits and bladder cancer risk: A case-control study
24. Tobacco and bladder cancer in males: Increased risk for inhalers and smokers of black tobacco
25. Cigarette smoking and bladder cancer
26. Black tobacco, mate, and bladder cancer. A case-control study from Uruguay
27. Tobacco smoking, occupational exposure and bladder cancer in Argentina
28. Bladder cancer and black tobacco cigarette smoking. Some results from a French case-control study
29. Tobacco and cancer: Epidemiology and the laboratory
30. Effects of timing and type of tobacco in cigarette-induced bladder cancer
31. Blasengeschwülste bei fuchsin-arbeitern
32. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine
33. Bladder tumor incidence among workers exposed to benzidine: A thirty-year follow-up
34. Mortality and incidence of bladder cancer in benzidine-exposed workers in China
35. Incidence of bladder cancer in a cohort of workers exposed to 4-chloro-o-toluidine while synthesising chlordimeform
36. The carcinogenic effect of aromatic amines: An epidemiological study on the role of o-toluidine and 4,4′-methylene bis(2-methylaniline) in inducing bladder cancer in man
37. Epidemiology and etiology of bladder cancer
38. Bladder cancer epidemiology
39. Occupational cancer of the urinary tract
40. Carcinomas of the urinary bladder in a 4-chloro-o-toluidine cohort
41. Bladder tumors in two young males occupationally exposed to MBOCA
42. Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline
43. Cancer mortality in the British rubber industry
44. Cancer mortality in a northern Italian cohort of rubber workers
45. Cohort mortality study of 57,000 painters and other union members: A 15 year update
46. Cancer risks in painters: Study based on the New Zealand Cancer Registry
47. Occupation and risk of cancer of the lower urinary tract among men. A case-control study
48. Occupation and cancer of the lower urinary tract
49. Disability, mortality, and incidence of cancer among Geneva painters and electricians: A historical prospective study
50. The Copenhagen case-referent study on bladder cancer. Risks among drivers, painters and certain other occupations
51. Occupation and the risk of bladder cancer
52. A cohort mortality study of painters and allied tradesmen
53. Cancer risk among artistic painters
54. Tumors of the urinary bladder in painters: A case-control study
55. A meta-analysis of bladder cancer and diesel exhaust exposure
56. Occupation and cancer in London: An investigation into nasal and bladder cancer using the Cancer Atlas
57. Truck driving and bladder cancer mortality in rural New England
58. Life style and occupational risk factors for bladder cancer in Germany. A case-control study
59. Occupational risk factors for bladder cancer: Results from a case-control study in Montreal, Quebec, Canada
60. Occupation and cancer of the lower urinary tract in Detroit
61. Motor exhaust-related occupations and bladder cancer
62. Tobacco and occupation as risk factors in bladder cancer: A case-control study in southern Belgium
63. A case-control study of bladder cancer using city directories as a source of occupational data
64. Occupational factors and the incidence of cancer of the bladder in Canada
65. Cancer incidence in urban bus drivers and tramway employees: A retrospective cohort study
66. Estimating the relationship between exposure to tar volatiles and the incidence of bladder cancer in aluminum smelter workers
67. Mortality of aluminum reduction plant workers, 1950 through 1977
68. Mortality and cancer incidence in aluminum reduction plant workers
69. Bladder cancer in the aluminium industry
70. Estimation of risk of developing bladder cancer among workers exposed to coal tar pitch volatiles in the primary aluminum industry
71. Cancer incidence among workers in six Norwegian aluminum plants
72. Cancer risks associated with employment in the leather and leather products industry
73. Cancer mortality among shoe and leather workers in Massachusetts
74. Bladder cancer and occupational exposure to leather
75. Occupation and bladder cancer in Boston, USA, Manchester, UK, and Nagoya, Japan
76. Occupation and bladder cancer in males: A case-control study
77. Drinking water source and chlorination byproducts. I. Risk of bladder cancer
78. Case-control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada)
79. Chlorination, chlorination by-products, and cancer: A meta-analysis
80. Bladder cancer mortality associated with arsenic in drinking water in Argentina
81. Incidence of transitional cell carcinoma and arsenic in drinking water: A follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan
82. Radiation dose and second cancer risk in patients treated for cancer of the cervix
83. Cancer mortality following radium treatment for uterine bleeding
84. Risk of urinary tract cancers following kidney or ureter stones
85. Urinary tract infection and risk of bladder cancer
86. Genital and urinary tract diseases and bladder cancer
87. Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women
88. Heavy phenacetin use and bladder cancer in women aged 20 to 49 years
89. Role of schistosomiasis in human bladder cancer: Evidence of association, aetiological factors, and basic mechanisms of carcinogenesis
90. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt
91. Relationship between schistosomiasis and bladder cancer
92. NAT2 slow acetylation and bladder cancer risk: A meta-analysis of 22 case-control studies conducted in the general population
93. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: A case-series meta-analysis of a gene-environment interaction
94. N-Acetyl transferase-2 and bladder cancer risk: A meta-analysis
95. Genetic metabolic polymorphisms and the risk of cancer: A review of the literature
96. Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: A meta-analysis
97. CYP1A2 activity as a risk factor for bladder cancer
98. Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population
99. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations
100. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: Influence on cancer susceptibility
101. Bladder cancer epidemiology and pathogenesis
102. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer
103. Genetic polymorphism of GSTM1, CYP2E1, and CYP2D6 in Egyptian bladder cancer patients
104. Influence of smoking in the glutathione-S-transferase M1 deficiency-associated risk for squamous cell carcinoma of the bladder in schistosomiasis patients in Egypt
105. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder
106. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts
107. Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers
108. International collaborative study on genetic susceptibility to environmental carcinogens
109. Human leukocyte glutathione S-transferase isozyme (class mu) and susceptibility to smoking-related cancers
110. Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers
111. Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer
112. Ethnic distribution of the glutathione transferase mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility
113. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk
114. Homozygous deleted genotype of glutathione S-transferase M1 increases susceptibility to aggressive bladder cancer
115. Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer
116. Glutathione S-transferase null genotypes in transitional cell bladder cancer: A case-control study
117. A germline homozygote deletion of the glutathione-S-transferase mu1 gene pre-disposes to bladder cancer
118. Glutathione S-transferase mu as a risk factor in bladder tumours
119. White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer
120. The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer
121. Gender-specific effects of NAT2 and GSTM1 in bladder cancer
122. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer
123. Association of glutathione S-transferase (GST) M1, GSTT1 and N-acetyl transferase 1 (NAT1) gene polymorphisms and bladder cancer in Korean men
124. Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk
125. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis
126. Meta-analysis in clinical trials
127. Some statistical methods for combining experimental results
128. A general parametric approach to the meta-analysis of randomized clinical trials
129. Operating characteristics of a rank correlation test for publication bias
130. Bias in meta-analysis detected by a simple, graphical test
131. Joint effect of genes and environment distorted by selection biases: Implications for hospital-based case-control studies
132. Gender- and smoking-related bladder cancer risk
133. Urothelial cancer at different tumour sites: Role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study
134. The Copenhagen case-control study of bladder cancer: Role of smoking in invasive and non-invasive bladder tumours
135. Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa
136. Statistical analysis of molecular epidemiology studies employing case-series
137. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: Case-control studies with no controls!
138. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies
139. Designing and analysing case-control studies to exploit independence of genotype and exposure
140. Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients
141. Bias in location and selection of studies
142. On estimating the relationship between blood group and disease